Focal liver lesions other than hepatocellular carcinoma in cirrhosis: Diagnostic challenges-Reference-Cited by-同舟云学术

Focal liver lesions other than hepatocellular carcinoma in cirrhosis: Diagnostic challenges

Published:2022-12-01 Issue:4 Volume:10 Page:308-327
ISSN:2224-4018
Container-title:Journal of Translational Internal Medicine
language:en
Short-container-title:

Author:

Möller Kathleen¹,Safai Zadeh Ehsan²,Görg Christian²,Dong Yi³,Cui Xinwu⁴,Lim Adrian⁵,Molo Chiara de⁶,Serra Carla⁶,Martín Algíbez Ana⁷,Berzigotti Analisa⁷,Piscaglia Fabio⁸,Faiss Siegbert¹,Dietrich Christoph F.⁹

Affiliation:

1. SANA Hospital Lichtenberg, Medical Department I/Gastroenterology , Berlin 10365 , Germany

2. Interdisciplinary Center of Ultrasound Diagnostics, University Hospital Giessen and Marburg, Philipps University Marburg , Marburg 35033 , Germany

3. Department of Ultrasound, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine , Shanghai 200092 , China

4. Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan 430030 , Hubei Province , China

5. Imperial College London and Healthcare NHS Trust , London NW1 5QH , UK

6. Interventional, Diagnostic and Therapeutic Ultrasound Unit, Department of Medical and Surgical Sciences, IRCCS, Azienda Ospedaliero-Universitaria Sant' Orsola Malpighi Hospital , Bologna 40138 , Italy

7. University Clinic for Visceral Surgery and Medicine, INSELSPITAL, University Hospital of Bern , Bern 3010 , Switzerland

8. Division of Internal Medicine, Hepatobiliary and Immunoallergic Diseases, IRCCS Azienda Ospedaliero-Universitaria di Bologna , Bologna 40138 , Italy

9. Department of Internal Medicine (DAIM), Hirslanden Private Hospital Beau Site, Salem and Permanence , Bern CH-3013 , Switzerland

Abstract

Abstract Liver cirrhosis is associated with regenerative nodules and an increased risk of developing hepatocellular carcinoma (HCC). However, other benign and malignant liver lesions may also occur. Differentiating the other lesions from HCC is important for further therapeutic decisions. This review discusses the characteristics of non-HCC liver lesions in cirrhosis and their consequent appearance on contrast-enhanced ultrasonography (CEUS) with consideration of other imaging. Knowledge of this data would be helpful in avoiding misdiagnoses.

Publisher

Walter de Gruyter GmbH

Subject

Internal Medicine

Link

https://www.degruyter.com/document/doi/10.2478/jtim-2022-0068/pdf

Reference112 articles.

1. Ridola L, Faccioli J, Nardelli S, Gioia S, Riggio O. Hepatic Encephalopathy: Diagnosis and Management. J Transl Intern Med 2020;8:210–9.

2. Tasneem AA, Luck NH. Autoimmune Hepatitis: Clinical Characteristics and Predictors of Biochemical Response to Treatment J Transl Intern Med 2020;8:106–11.

3. Mittal S, El-Serag HB. Epidemiology of hepatocellular carcinoma: consider the population. J Clin Gastroenterol 2013;4:S2–6.

4. Yu MW, Hsu FC, Sheen IS, Chu CM, Lin DY, Chen CJ, et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997;145:1039–47.

5. Pocha C, Xie C. Hepatocellular carcinoma in alcoholic and non-alcoholic fatty liver disease-one of a kind or two different enemies? Transl Gastroenterol Hepatol 2019;4:72.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigallocatechin Gallate Derivative Y6 Reverses Oxaliplatin Resistance in Hepatocellular Carcinoma via Targeting the MiR-338-3p/HIF-1α/TWIST Axis to Inhibit EMT;Recent Patents on Anti-Cancer Drug Discovery;2024-07-11

2. Omics-imaging signature-based nomogram to predict the progression-free survival of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization;World Journal of Clinical Cases;2024-06-26

3. Incidental findings of gallbladder and bile ducts – Management strategies: Normal findings, anomalies, “silent gallstones” and bile duct dilatation - A World Federation of Ultrasound in Medicine and Biology (WFUMB) position paper;WFUMB Ultrasound Open;2024-06

4. Diagnostic Performance of Modified Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in Patients Without Risk Factors for Hepatocellular Carcinoma: Comparison With World Federation for Ultrasound in Medicine and Biology Guideline;Ultrasound in Medicine & Biology;2024-02

5. Comments and illustrations of the WFUMB CEUS liver guidelines: Rare focal liver lesion – infectious parasitic, fungus;Medical Ultrasonography;2023-12-27